JP2025060641A5 - - Google Patents
Info
- Publication number
- JP2025060641A5 JP2025060641A5 JP2024213225A JP2024213225A JP2025060641A5 JP 2025060641 A5 JP2025060641 A5 JP 2025060641A5 JP 2024213225 A JP2024213225 A JP 2024213225A JP 2024213225 A JP2024213225 A JP 2024213225A JP 2025060641 A5 JP2025060641 A5 JP 2025060641A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- approximately
- less
- administration
- patient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862773894P | 2018-11-30 | 2018-11-30 | |
| US62/773,894 | 2018-11-30 | ||
| US201962835242P | 2019-04-17 | 2019-04-17 | |
| US62/835,242 | 2019-04-17 | ||
| PCT/US2019/063649 WO2020113034A1 (en) | 2018-11-30 | 2019-11-27 | Aav viral vectors and uses thereof |
| JP2021530078A JP7677887B2 (ja) | 2018-11-30 | 2019-11-27 | Aavウイルスベクター及びその使用 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021530078A Division JP7677887B2 (ja) | 2018-11-30 | 2019-11-27 | Aavウイルスベクター及びその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025060641A JP2025060641A (ja) | 2025-04-10 |
| JP2025060641A5 true JP2025060641A5 (cg-RX-API-DMAC7.html) | 2025-10-23 |
| JP7808674B2 JP7808674B2 (ja) | 2026-01-29 |
Family
ID=69167903
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021530078A Active JP7677887B2 (ja) | 2018-11-30 | 2019-11-27 | Aavウイルスベクター及びその使用 |
| JP2024213225A Active JP7808674B2 (ja) | 2018-11-30 | 2024-12-06 | Aavウイルスベクター及びその使用 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021530078A Active JP7677887B2 (ja) | 2018-11-30 | 2019-11-27 | Aavウイルスベクター及びその使用 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20220001028A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3886919A1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7677887B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20210099025A (cg-RX-API-DMAC7.html) |
| CN (2) | CN120860258A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2019389047A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112021009739A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3116630A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL282885A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2021006359A (cg-RX-API-DMAC7.html) |
| TW (2) | TWI844587B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020113034A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2021534154A (ja) * | 2018-08-15 | 2021-12-09 | バイオジェン・エムエイ・インコーポレイテッドBiogen MA Inc. | 脊髄性筋萎縮症のための併用療法 |
| TW202140791A (zh) * | 2020-01-13 | 2021-11-01 | 美商霍蒙拉奇醫藥公司 | 治療苯酮尿症之方法 |
| CN112121179A (zh) * | 2020-09-15 | 2020-12-25 | 山东兴瑞生物科技有限公司 | 一种组合物及其在治疗脊髓性肌萎缩症中的应用 |
| WO2022155364A1 (en) * | 2021-01-13 | 2022-07-21 | Dignity Health | Modulation of chitinase protein expression |
| AU2022318664A1 (en) | 2021-07-30 | 2024-02-29 | Tune Therapeutics, Inc. | Compositions and methods for modulating expression of methyl-cpg binding protein 2 (mecp2) |
| US20240254483A1 (en) | 2021-07-30 | 2024-08-01 | Tune Therapeutics, Inc. | Compositions and methods for modulating expression of frataxin (fxn) |
| EP4380602A4 (en) * | 2021-08-03 | 2025-06-11 | The Regents Of The University Of California | ADENO-ASSOCIATED VIRAL (AAV)-MEDIATED EXPRESSION OF SPHINGOSINE 1-PHOSPHATE LYASE (SPL) FOR THE TREATMENT OF PULMONARY FIBROSIS |
| CN114276419B (zh) * | 2021-12-30 | 2023-11-17 | 上海勉亦生物科技有限公司 | 肌肉高亲和性的新型腺相关病毒衣壳蛋白及其应用 |
| KR20230152503A (ko) * | 2022-04-27 | 2023-11-03 | 주식회사 헬릭스미스 | 척수강 내 투여에 최적화 된 간세포 성장인자 유전자가 도입된 aav 벡터 |
| KR102717399B1 (ko) * | 2022-05-10 | 2024-10-16 | 서울대학교산학협력단 | 인간 smn1 단백질 변이체 및 이의 용도 |
| AU2023288029A1 (en) | 2022-06-21 | 2025-02-13 | Skyline Therapeutics Limited | Recombinant aav for the gene therapy of sma disease |
| EP4554967A2 (en) | 2022-07-12 | 2025-05-21 | Tune Therapeutics, Inc. | Compositions, systems, and methods for targeted transcriptional activation |
| WO2024163678A2 (en) | 2023-02-01 | 2024-08-08 | Tune Therapeutics, Inc. | Fusion proteins and systems for targeted activation of frataxin (fxn) and related methods |
| WO2024163683A2 (en) | 2023-02-01 | 2024-08-08 | Tune Therapeutics, Inc. | Systems, compositions, and methods for modulating expression of methyl-cpg binding protein 2 (mecp2) and x-inactive specific transcript (xist) |
| JP2026517212A (ja) * | 2023-05-18 | 2026-05-28 | ウルトラジェニックス ファーマシューティカル インコーポレイテッド | 組換えaavを含む製剤およびその投与方法 |
| WO2026028089A1 (en) | 2024-07-29 | 2026-02-05 | Novartis Ag | Compositions and methods for the treatment of lysosomal acid lipase deficiency (lal-d) |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5173414A (en) | 1990-10-30 | 1992-12-22 | Applied Immune Sciences, Inc. | Production of recombinant adeno-associated virus vectors |
| DE69433922T2 (de) | 1993-11-09 | 2005-07-28 | Medical College Of Ohio, Toledo | Stabile zellinie, die in der lage ist, das replikationsgen des adenoassoziertenvirus zu exprimieren |
| EP0733103B1 (en) | 1993-11-09 | 2004-03-03 | Targeted Genetics Corporation | Generation of high titers of recombinant aav vectors |
| US5658785A (en) | 1994-06-06 | 1997-08-19 | Children's Hospital, Inc. | Adeno-associated virus materials and methods |
| US5856152A (en) | 1994-10-28 | 1999-01-05 | The Trustees Of The University Of Pennsylvania | Hybrid adenovirus-AAV vector and methods of use therefor |
| WO1996017947A1 (en) | 1994-12-06 | 1996-06-13 | Targeted Genetics Corporation | Packaging cell lines for generation of high titers of recombinant aav vectors |
| FR2737730B1 (fr) | 1995-08-10 | 1997-09-05 | Pasteur Merieux Serums Vacc | Procede de purification de virus par chromatographie |
| JPH11511326A (ja) | 1995-08-30 | 1999-10-05 | ジエンザイム コーポレイション | アデノウィルスおよびaavの精製 |
| JPH11514853A (ja) | 1995-09-08 | 1999-12-21 | ジエンザイム コーポレイション | 遺伝子治療のための改良されたaavベクター |
| US5910434A (en) | 1995-12-15 | 1999-06-08 | Systemix, Inc. | Method for obtaining retroviral packaging cell lines producing high transducing efficiency retroviral supernatant |
| CA2995542A1 (en) | 1997-09-05 | 1999-03-11 | Genzyme Corporation | Methods for generating high titer helper-free preparations of recombinant aav vectors |
| US6258595B1 (en) | 1999-03-18 | 2001-07-10 | The Trustees Of The University Of Pennsylvania | Compositions and methods for helper-free production of recombinant adeno-associated viruses |
| JP2004514407A (ja) | 2000-04-28 | 2004-05-20 | ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア | 異種キャプシド中にシュードタイピングされたaav5キャプシドおよびaav5ベクターを含む組換えaavベクター |
| EP1463805B1 (en) | 2001-12-17 | 2014-10-22 | The Trustees of The University of Pennsylvania | Adeno-associated virus (aav) serotype 9 sequences, vectors containing same, and uses therefor |
| US9441244B2 (en) | 2003-06-30 | 2016-09-13 | The Regents Of The University Of California | Mutant adeno-associated virus virions and methods of use thereof |
| US9233131B2 (en) | 2003-06-30 | 2016-01-12 | The Regents Of The University Of California | Mutant adeno-associated virus virions and methods of use thereof |
| EP1668143B1 (en) * | 2003-09-30 | 2013-03-20 | The Trustees of The University of Pennsylvania | Adeno-associated virus (aav) clades, sequences, vectors containing same, and uses therefor |
| PT2548560E (pt) | 2005-06-23 | 2015-09-22 | Isis Pharmaceuticals Inc | Composições e métodos de modulação da excisão-união de smn2 |
| KR20220084437A (ko) | 2009-06-17 | 2022-06-21 | 바이오젠 엠에이 인코포레이티드 | 대상에게서 smn2 스플라이싱을 조정하기 위한 조성물 및 방법 |
| EP2529020B1 (en) * | 2010-01-28 | 2018-04-25 | The Children's Hospital of Philadelphia | A scalable manufacturing platform for viral vector purification and viral vectors so purified for use in gene therapy |
| DE102012007232B4 (de) | 2012-04-07 | 2014-03-13 | Susanne Weller | Verfahren zur Herstellung von rotierenden elektrischen Maschinen |
| CA2880653C (en) * | 2012-08-01 | 2022-05-17 | Nationwide Children's Hospital | Intrathecal delivery of recombinant adeno-associated virus 9 |
| BR112015027336A2 (pt) * | 2013-05-01 | 2017-09-26 | Genzyme Corp | composições e processos para tratamento de atrofia muscular espinhal |
| JP2016523835A (ja) * | 2013-05-15 | 2016-08-12 | リージェンツ オブ ザ ユニバーシティ オブ ミネソタ | 中枢神経系へのアデノ随伴ウイルスを介した遺伝子導入 |
| JP2015092462A (ja) | 2013-09-30 | 2015-05-14 | Tdk株式会社 | 正極及びそれを用いたリチウムイオン二次電池 |
| AU2014340149B2 (en) * | 2013-10-22 | 2020-12-24 | Shire Human Genetic Therapies, Inc. | CNS delivery of mRNA and uses thereof |
| JP6756700B2 (ja) * | 2014-03-18 | 2020-09-16 | ユニバーシティ オブ マサチューセッツ | 筋萎縮性側索硬化症を処置するためのrAAVベースの組成物および方法 |
| WO2015141521A1 (ja) | 2014-03-21 | 2015-09-24 | 株式会社日立国際電気 | 基板処理装置、半導体装置の製造方法及び記録媒体 |
| JP6197169B2 (ja) | 2014-09-29 | 2017-09-20 | 東芝メモリ株式会社 | 半導体装置の製造方法 |
| CA3068328A1 (en) * | 2017-07-06 | 2019-01-10 | The Trustees Of The University Of Pennsylvania | Aav9-mediated gene therapy for treating mucopolysaccharidosis type i |
| EP4585229A3 (en) * | 2017-11-08 | 2026-01-14 | Novartis AG | Means and method for preparing viral vectors and uses of same |
-
2019
- 2019-11-27 EP EP19836872.2A patent/EP3886919A1/en active Pending
- 2019-11-27 TW TW108143173A patent/TWI844587B/zh active
- 2019-11-27 CN CN202511011473.6A patent/CN120860258A/zh active Pending
- 2019-11-27 CA CA3116630A patent/CA3116630A1/en active Pending
- 2019-11-27 JP JP2021530078A patent/JP7677887B2/ja active Active
- 2019-11-27 TW TW113118096A patent/TWI897418B/zh active
- 2019-11-27 BR BR112021009739-2A patent/BR112021009739A2/pt unknown
- 2019-11-27 MX MX2021006359A patent/MX2021006359A/es unknown
- 2019-11-27 US US17/309,403 patent/US20220001028A1/en active Pending
- 2019-11-27 CN CN201980078349.8A patent/CN113226380A/zh active Pending
- 2019-11-27 WO PCT/US2019/063649 patent/WO2020113034A1/en not_active Ceased
- 2019-11-27 KR KR1020217019147A patent/KR20210099025A/ko not_active Ceased
- 2019-11-27 AU AU2019389047A patent/AU2019389047A1/en not_active Abandoned
-
2021
- 2021-05-03 IL IL282885A patent/IL282885A/en unknown
-
2024
- 2024-12-06 JP JP2024213225A patent/JP7808674B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022511776A5 (cg-RX-API-DMAC7.html) | ||
| US12409235B2 (en) | Gene therapy for AADC deficiency | |
| JP7808674B2 (ja) | Aavウイルスベクター及びその使用 | |
| JP2021502123A5 (cg-RX-API-DMAC7.html) | ||
| Galletta et al. | Hemophagocytic lymphohistiocytosis following gene replacement therapy in a child with type 1 spinal muscular atrophy | |
| CN101084009B (zh) | Gh促分泌素及其用途 | |
| PT1326644E (pt) | Potenciadores da absorção | |
| JP2024517143A5 (cg-RX-API-DMAC7.html) | ||
| CN115554418A (zh) | 一种重组腺相关病毒载体的药物组合物及其用途 | |
| JP2025514978A (ja) | 脊髄性筋萎縮症を治療するためのミオスタチン阻害薬の使用 | |
| WO2025038800A1 (en) | Compositions and methods for the treatment of disorders related to frataxin deficiency | |
| RU2021118669A (ru) | Вирусные векторы на основе aav и пути их применения | |
| JP3640980B2 (ja) | ネコの呼吸器疾患治療剤とその治療剤を用いる治療方法 | |
| Singh et al. | Review of therapeutic options for spinal muscular atrophy | |
| EP3463376A1 (en) | New treatment of sma | |
| JP2022518354A5 (cg-RX-API-DMAC7.html) | ||
| JP4629964B2 (ja) | ウシの消化器疾患治療剤 | |
| JP3034032B2 (ja) | 腸疾患用薬剤 | |
| Ozawa et al. | Renal function in patients with Menkes disease | |
| Intragumtornchai et al. | Obstructive uropathy due to extramedullary haematopoiesis in beta thalassaemia/haemoglobin E | |
| RU2796274C2 (ru) | Вирусные векторы на основе aav и пути их применения | |
| TW202606762A (zh) | 治療t細胞淋巴瘤之組合物及方法 | |
| JP2003518076A (ja) | コスミドdna構築物およびその作製および使用方法 | |
| JP2022145646A5 (cg-RX-API-DMAC7.html) | ||
| TH2001002503A (th) | วิถีทางและวิธีการสำหรับเตรียมเวกเตอร์ไวรัส และการใช้สิ่งดังกล่าว |